updated 1/5/2011 8:46:19 AM ET 2011-01-05T13:46:19

CAMBRIDGE, Mass., Jan. 5, 2011 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) will be presenting at the J.P. Morgan 29th Annual Healthcare Conference on Thursday, January 13, 2011 at 1:30 p.m. PST (4:30 p.m. EST) in San Francisco.

A live webcast of Infinity's presentation will be accessible on the "investors/media" section of the company's website, www.infi.com , and will be available for 30 days following the event.

About Infinity Pharmaceuticals, Inc.

Infinity is an innovative drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity's programs in the inhibition of the Hedgehog pathway, the Hsp90 chaperone system, fatty acid amide hydrolase, and phosphoinositide-3-kinase are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company's website at http://www.infi.com.

CONTACT:  Infinity Pharmaceuticals, Inc.
          Jaren Irene Madden
          617-453-1336
          Jaren.Madden@infi.com
          http://www.infi.com

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 4.93%
$30K home equity loan FICO 5.20%
$75K home equity loan FICO 4.58%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.42%
13.40%
Cash Back Cards 17.92%
17.91%
Rewards Cards 17.13%
17.11%
Source: Bankrate.com